Search results
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 21 hours agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
Hand Rash: 12 Possible Causes and Treatment Options
Verywell Health via Yahoo News· 2 days agoA hand rash can result from allergic reactions, exposure to irritants, and sunburn. Health conditions like eczema and psoriasis can also cause hand...
Eczema Risk Increased in Older Adults on Antihypertensives
Medscape· 4 days agoUse of antihypertensive drugs was associated with a small increase in the rate of eczematous ...
Indoor tanning and eczema: Benefits, risks, and tanning tips
Medical News Today· 2 days agoModerate sun exposure and phototherapy may help improve eczema. Phototherapy uses controlled...
J&J acquires experimental skin disorder drug for $1.25 billion
Reuters via AOL· 3 days agoJ&J will acquire a unit of Numab, backed by the parent of Danish drugmaker Novo Nordisk, to gain...
J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal
Bloomberg· 3 days agoHave a confidential tip for our reporters? Johnson & Johnson agreed to pay $1.25 billion for the...
Skin biopsy for eczema: Purpose, procedure, and next steps
Medical News Today· 2 days agoSkin biopsies can help diagnose eczema, but they are not usually necessary. Most times, doctors can...
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 2 days agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
Why Do I Have a Rash Between My Breasts?
Verywell Health via Yahoo News· 7 days agoA rash between the breasts can develop for a variety of reasons, including heat, infection, or other more serious conditions like cancer. Here’s what to...
This Chronic Skin Condition Is Often Mistaken For Acne. Here's How To Tell The Difference.
Women's Health via AOL· 1 day ago“If and when over-the counter moisturizers and the avoidance of triggers are not helping resolve...